Pluri (PLUR) Current Assets (2011 - 2025)
Pluri's (PLUR) quarterly Current Assets came in at $13.8 million in Q4 2025, down 38.29% year-over-year from $22.4 million in Q4 2024, and down 18.42% quarter-over-quarter from $16.9 million in Q3 2025.
Analysis
Pluri (PLUR) Current Assets (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Current Assets for 15 consecutive years, with $13.8 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Current Assets fell 38.29% year-over-year to $13.8 million in Q4 2025; TTM through Dec 2025 was $13.8 million, a 38.29% decrease from a year earlier, with the FY2025 full-year figure at $22.1 million, down 28.97% from the prior year.
- Current Assets was $13.8 million for Q4 2025 at Pluri, down from $16.9 million in the prior quarter.
- Over five years, Current Assets peaked at $67.4 million in Q2 2021 and troughed at $13.8 million in Q4 2025.
- A 5-year average of $40.3 million and a median of $38.3 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 179.59% in 2021 and sank 41.38% in 2024, its largest moves.
- Over 5 years, Current Assets stood at $60.2 million in 2021, then slipped by 16.65% to $50.1 million in 2022, then tumbled by 35.68% to $32.3 million in 2023, then tumbled by 30.64% to $22.4 million in 2024, then plunged by 38.29% to $13.8 million in 2025.
- The last three Current Assets figures came in at $13.8 million (Q4 2025), $16.9 million (Q3 2025), and $22.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.06 Bn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.37 Bn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 464.26 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.23 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 834.27 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.18 Bn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 134.38 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 2.22 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 264.73 Mn |
| 10 | Pluri | 11.95 Mn | -536,034.04 | 86,000.00 | 13.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 13.80 Mn |
| Sep 30, 2025 | 16.92 Mn |
| Jun 30, 2025 | 22.10 Mn |
| Mar 31, 2025 | 27.46 Mn |
| Dec 31, 2024 | 22.37 Mn |
| Sep 30, 2024 | 27.03 Mn |
| Jun 30, 2024 | 31.11 Mn |
| Mar 31, 2024 | 27.37 Mn |
| Dec 31, 2023 | 32.25 Mn |
| Sep 30, 2023 | 35.26 Mn |
| Jun 30, 2023 | 41.41 Mn |
| Mar 31, 2023 | 46.69 Mn |
| Dec 31, 2022 | 50.14 Mn |
| Sep 30, 2022 | 49.72 Mn |
| Jun 30, 2022 | 57.75 Mn |
| Mar 31, 2022 | 64.31 Mn |
| Dec 31, 2021 | 60.15 Mn |
| Sep 30, 2021 | 62.83 Mn |
| Jun 30, 2021 | 67.37 Mn |
| Mar 31, 2021 | 49.82 Mn |